Post-market European & Asian Registry to Evaluate the Minos™ Stent-Graft and Delivery System in Abdominal Aortic Aneurysm Treatment

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorShanghai MicroPort Endovascular MedTech(Group)Co., Ltd

About this trial

The Minos™ Abdominal Aortic Stent-Graft and Delivery System is a medical device designed to treat abdominal aortic aneurysms using a minimally invasive procedure. The device is placed inside the aorta through blood vessels, usually accessed through small incisions in the groin. The goal of this observational study is to collect short-, medium- to long-term safety and performance data of the Minos™ stent-graft in everyday medical practice (real-world settings). The aim is to study about 200 patients worldwide and at least 30 patients in European hospitals.

Eligibility criteria

Qualifiers

Diagnosis of infrarenal abdominal aortic aneurysm

Plan to treat with Minos Abdominal Aortic Stent-Graft and Delivery System

Voluntary participation and completion of Informed Consent Form, with willingness to participate in follow-up to 5 years post-procedure

Disqualifiers

Severe stenosis or calcification near the aneurysm, leading to difficulty in achieving apposition of vessel wall and stent graft.

Difficult access due to severe stenosis or tortuosity in the iliac artery or femoral artery.

Subjects with ruptured aneurysm or acute aneurysm.

Subjects with an infectious aneurysm.

Trial design

Treatments tested in this trial

  • Implantation with Minos Stent graft

Treatment groups

200 Participants
are divided into 1 treatment group